Detailed price information for Aclaris Therapts (ACRS-Q) from The Globe and Mail including charting and trades.

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Current asthma biologics require frequent dosing.

Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage biopharmaceutical company focused on developing novel product ...

The cytokine thymic stromal lymphopoietin (TSLP) has previously been linked to allergic inflammatory diseases in humans. Now, three recent studies have confirmed that TSLP is a key initiator of ...

Many children who get a severe skin rash develop asthma months or years later. Doctors call the progression from eczema to breathing problems the atopic march. Now scientists have uncovered what might ...

Upstream Bio Inc. (NASDAQ:UPB) is one of the best hot stocks to invest in. On September 30, Upstream Bio presented new structural and mechanistic data for its therapeutic candidate, verekitug, at the ...

The TSLP inhibitors market is witnessing steady growth, driven by the increasing prevalence of asthma, atopic dermatitis, and other allergic inflammatory diseases. Rising adoption of targeted ...

Please provide your email address to receive an email when new articles are posted on . The treatment group had reductions in FeNO 1 week after a single dose. Reductions were significant compared with ...

Thymic stromal lymphopoietin (TSLP) is an interleukin-7-like cytokine that is associated with the pathology of atopic dermatitis and asthma. Although the role of this cytokine has been studied in ...

- Pharmacology modeling data presented at the European Academy of Allergy & Clinical Immunology (EAACI) Congress describe mechanistic insights for greater potency with verekitug compared to ...

This is a preview. Log in through your library . Abstract We previously reported that selective ablation of the nuclear receptors retinoid X receptor (RXR)-α and RXR-β in mouse epidermal keratinocytes ...